A - Agilent Technologies, Inc. Stock Price, Fair Value and News

139.17USD+5.26 (+3.93%)Market Closed

Market Summary

USD139.17+5.26

Market Closed

3.93%

A Alerts

1 major insider sales recently.

A Stock Price

View Fullscreen

A RSI Chart

A Valuation

Market Cap

40.8B

Price/Earnings (Trailing)

Price/Sales (Trailing)

6.06

EV/EBITDA

24.61

Price/Free Cashflow

24.73

A Price/Sales (Trailing)

A Profitability

Operating Margin

67.57%

EBT Margin

19.78%

Return on Equity

19.97%

Return on Assets

11.29%

Free Cashflow Yield

4.04%

A Fundamentals

A Revenue

Revenue (TTM)

6.7B

Rev. Growth (Yr)

-5.58%

Rev. Growth (Qtr)

-1.78%

A Earnings

Earnings (TTM)

1.2B

Earnings Growth (Yr)

-1.14%

Earnings Growth (Qtr)

-26.74%

Breaking Down A Revenue

Last 7 days

1.7%

Last 30 days

-5.6%

Last 90 days

7.2%

Trailing 12 Months

0.5%

How does A drawdown profile look like?

A Financial Health

Current Ratio

2.68

Debt/Equity

0.41

Debt/Cashflow

0.77

A Investor Care

Dividend Yield

0.65%

Dividend/Share (TTM)

0.91

Buy Backs (1Y)

0.90%

Diluted EPS (TTM)

4.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	6.7B	0	0	0
2023	6.9B	7.0B	7.0B	6.8B
2022	6.4B	6.5B	6.7B	6.8B
2021	5.5B	5.8B	6.1B	6.3B
2020	5.2B	5.2B	5.2B	5.3B
2019	5.0B	5.0B	5.1B	5.2B
2018	4.6B	4.7B	4.8B	4.9B
2017	4.2B	4.3B	4.4B	4.5B
2016	4.0B	4.1B	4.1B	4.2B
2015	4.1B	4.0B	4.0B	4.0B
2014	3.9B	4.0B	4.0B	4.0B
2013	6.9B	6.9B	6.8B	3.9B
2012	6.7B	6.8B	6.8B	6.9B
2011	5.8B	6.2B	6.5B	6.6B
2010	4.5B	4.7B	5.0B	5.4B
2009	5.5B	5.1B	4.8B	4.5B
2008	0	0	5.6B	5.8B
2007	0	0	0	5.4B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Agilent Technologies, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 25, 2024	binns philip	sold	-417,096	147	-2,827	senior vice president
Mar 15, 2024	fields heidi	acquired	247,471	147	1,678	-
Mar 15, 2024	bishop hans edgar	acquired	358,081	147	2,428	-
Mar 15, 2024	anand mala	acquired	247,471	147	1,678	-
Mar 15, 2024	rataj sue h.	acquired	247,471	147	1,678	-
Mar 15, 2024	wilson dow r	acquired	247,471	147	1,678	-
Mar 15, 2024	scangos george a	acquired	247,471	147	1,678	-
Mar 15, 2024	koh boon hwee	acquired	247,471	147	1,678	-
Mar 15, 2024	brawley otis w	acquired	358,081	147	2,428	-
Mar 15, 2024	koh boon hwee	sold (taxes)	-74,329	147	-504	-

Which funds bought or sold A recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	Rosenberg Matthew Hamilton	unchanged	-	1,854	41,339	0.01%
Apr 22, 2024	Nilsine Partners, LLC	added	12.07	212,147	1,438,950	0.20%
Apr 22, 2024	PFG Investments, LLC	added	52.8	123,373	329,239	0.02%
Apr 22, 2024	ALTFEST L J & CO INC	added	1.23	21,000	370,000	0.05%
Apr 22, 2024	Sentry LLC	unchanged	-	17,794	399,570	0.07%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	added	22.36	4,095,750	18,690,300	0.01%
Apr 22, 2024	Horst & Graben Wealth Management LLC	reduced	-1.64	7,261	253,012	0.05%
Apr 22, 2024	PARSONS CAPITAL MANAGEMENT INC/RI	unchanged	-	12,669	284,473	0.02%
Apr 22, 2024	Oakworth Capital, Inc.	reduced	-0.08	7,681	175,630	0.01%
Apr 22, 2024	ROVIN CAPITAL /UT/ /ADV	reduced	-4.33	1,000	666,000	0.27%

Are Funds Buying or Selling A?

Are funds buying A calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own A

No. of Funds

A Alerts

1 major insider sales recently.

Unveiling Agilent Technologies, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	vanguard group inc	10.20%	29,882,462	SC 13G/A
Feb 13, 2024	vanguard group inc	8.63%	25,277,234	SC 13G/A
Jan 25, 2024	blackrock inc.	9.3%	27,257,254	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	2.6%	7,707,066	SC 13G/A
Feb 09, 2023	vanguard group inc	8.53%	25,250,988	SC 13G/A
Jan 26, 2023	blackrock inc.	10.9%	32,309,878	SC 13G/A
Jan 20, 2023	blackrock inc.	10.9%	32,309,878	SC 13G/A
Apr 08, 2022	blackrock inc.	10.0%	30,082,335	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	7.1%	21,689,105	SC 13G/A
Feb 09, 2022	vanguard group inc	8.04%	24,269,735	SC 13G/A

Recent SEC filings of Agilent Technologies, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 10, 2024	SC 13G/A	Major Ownership Report
Mar 27, 2024	4	Insider Trading
Mar 25, 2024	144	Notice of Insider Sale Intent
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading

Peers (Alternatives to Agilent Technologies, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	174.4B	23.7B	-0.66%	-0.48%	39.62	7.35	-8.94%	-35.72%
IDXX	41.0B	3.7B	-6.96%	-1.95%	48.55	11.21	8.72%	24.44%
A	40.8B	6.7B	-5.62%	0.50%	33	6.06	-2.81%	-6.58%
DGX	15.1B	9.3B	5.76%	-6.69%	17.73	1.64	-6.38%	-9.73%
CRL	12.3B	4.1B	-11.91%	17.80%	25.98	2.99	3.86%	-2.39%
EXAS	11.5B	2.5B	2.30%	-4.05%	-56.49	4.61	19.93%	67.26%
MEDP	11.5B	2.0B	-0.40%	117.42%	36.88	5.87	25.57%	21.62%
NTRA	11.0B	1.1B	-1.39%	71.77%	-25.28	10.16	31.99%	20.63%
MID-CAP
NEOG	2.7B	929.2M	-19.07%	-29.09%	1.7K	2.87	28.93%	111.61%
GH	2.1B	563.9M	0.58%	-24.79%	-4.4	3.74	25.45%	26.76%
SMALL-CAP
CDNA	426.1M	280.3M	-13.73%	-2.49%	-2.24	1.52	-12.89%	-148.37%
ACRS	86.5M	31.2M	6.09%	-86.56%	-0.98	2.77	5.03%	-1.81%
AWH	41.8M	9.2M	-7.12%	-37.22%	-2.51	4.57	11.85%	44.12%
APDN	4.9M	9.0M	-42.00%	-72.12%	-0.68	0.55	-53.31%	2.21%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Agilent Technologies, Inc. News

Latest updates

Agilent Technologies, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-1.8%	1,658	1,688	1,672	1,717	1,756	1,849	1,718	1,607	1,674	1,660	1,586	1,525	1,548	1,483	1,261	1,238	1,357	1,367	1,274	1,238	1,284
Costs and Expenses	-0.5%	1,274	1,280	1,539	1,334	1,330	1,378	1,307	1,247	1,298	1,265	1,250	1,237	1,220	1,184	1,031	1,136	1,142	1,117	1,049	1,022	1,034
S&GA Expenses	0.8%	396	393	407	415	419	422	412	386	417	389	403	420	407	387	347	358	404	385	366	354	355
R&D Expenses	12.3%	128	114	118	126	123	119	116	115	117	116	113	109	103	102	92.00	197	104	102	101	99.00	102
EBITDA Margin	0.6%	0.25*	0.25*	0.25*	0.29*	0.29*	0.28*	0.29*	0.28*	0.28*	0.28*	0.26*	0.25*	-	-	-	-	-	-	-	-	-
Interest Expenses	0%	22.00	22.00	24.00	24.00	25.00	23.00	19.00	21.00	21.00	21.00	21.00	20.00	19.00	19.00	19.00	20.00	20.00	21.00	18.00	17.00	18.00
Income Taxes	200.0%	55.00	-55.00	21.00	75.00	58.00	87.00	68.00	59.00	36.00	6.00	63.00	57.00	24.00	61.00	20.00	20.00	22.00	37.00	31.00	36.00	-256
Earnings Before Taxes	-4.0%	403	420	132	377	410	455	397	333	319	448	327	273	312	283	219	121	219	231	222	218	248
EBT Margin	0.9%	0.20*	0.20*	0.20*	0.23*	0.23*	0.22*	0.22*	0.22*	0.21*	0.22*	0.19*	0.19*	-	-	-	-	-	-	-	-	-
Net Income	-26.7%	348	475	111	302	352	368	329	274	283	442	264	216	288	222	199	101	197	194	191	182	504
Net Income Margin	1.1%	0.18*	0.18*	0.16*	0.19*	0.19*	0.18*	0.20*	0.19*	0.19*	0.19*	0.16*	0.16*	-	-	-	-	-	-	-	-	-
Free Cashflow	-8.6%	395	432	481	341	220	378	244	219	180	379	280	441	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.7%	10,948	10,763	10,675	10,792	10,919	10,532	10,484	10,455	10,327	10,705	10,491	10,398	9,674	9,627	9,546	9,455	9,501	9,452	8,625	9,022	8,952
Current Assets	3.6%	4,338	4,186	4,030	3,949	4,078	3,778	3,690	3,643	3,474	3,799	3,632	3,514	3,483	3,415	3,245	3,171	3,102	3,189	3,457	3,812	3,712
Cash Equivalents	9.9%	1,748	1,590	1,329	1,175	1,253	1,056	1,073	1,188	1,116	1,484	1,435	1,387	1,336	1,447	1,364	1,329	1,232	1,388	1,771	2,161	2,064
Inventory	0.2%	1,033	1,031	1,072	1,103	1,111	1,038	1,010	937	879	830	818	791	755	720	746	750	706	679	660	657	653
Net PPE	3.5%	1,314	1,270	1,211	1,184	1,147	1,100	1,054	1,010	974	945	905	884	866	845	846	836	844	850	839	827	829
Goodwill	0.2%	3,967	3,960	3,984	3,980	3,983	3,952	3,948	3,956	3,964	3,975	3,976	4,054	3,618	3,602	3,606	3,582	3,589	3,593	3,107	3,112	3,133
Liabilities	-3.2%	4,760	4,918	5,117	5,011	5,310	5,227	5,393	5,333	5,173	5,316	5,545	5,588	4,870	4,754	4,565	4,687	4,653	4,704	3,878	3,897	3,916
Current Liabilities	0.9%	1,617	1,603	1,760	1,666	1,936	1,861	1,902	1,813	1,584	1,708	1,724	1,758	1,687	1,467	1,314	1,945	1,892	2,080	1,622	1,118	1,095
Short Term Borrowings	-	-	-	55.00	-	238	36.00	180	175	-	-	130	205	314	75.00	40.00	700	675	616	504	-	-
Long Term Debt	-6.6%	2,555	2,735	2,734	2,733	2,733	2,733	2,732	2,730	2,730	2,729	2,728	2,727	2,185	2,284	2,283	1,788	1,787	1,791	1,294	1,798	1,798
LT Debt, Non Current	-	-	-	-	-	-	-	-	2,730	2,730	2,729	2,728	2,727	2,185	2,284	2,283	1,788	1,787	1,791	1,294	1,798	1,798
Shareholder's Equity	5.9%	6,188	5,845	5,558	5,781	541	5,305	139	5,292	159	5,389	90.00	4,810	4,804	3.00	130	5,288	3.00	4,748	4,747	5,125	5,036
Retained Earnings	35.7%	1,061	782	444	700	541	324	139	160	159	348	90.00	-12.00	4.00	81.00	130	15.00	73.00	-18.00	-122	178	90.00
Additional Paid-In Capital	1.0%	5,440	5,387	5,382	5,360	5,345	5,325	5,311	5,292	5,290	5,320	5,307	5,271	5,266	5,311	5,324	5,288	5,293	5,277	5,270	5,343	5,324
Shares Outstanding	0.3%	293	292	293	295	296	295	298	299	301	304	305	305	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	31,200	-	-	-	26,600	-	-	-	30,900	-	-	-	18,000	-	-	-	18,900	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-6.0%	485	516	562	398	296	448	326	283	255	441	334	472	238	377	290	313	-59.00	314	242	252	213
Share Based Compensation	214.3%	44.00	14.00	29.00	24.00	44.00	26.00	28.00	27.00	44.00	22.00	22.00	26.00	40.00	20.00	19.00	17.00	27.00	15.00	17.00	16.00	24.00
Cashflow From Investing	-137.5%	-95.00	-40.00	-89.00	-77.00	-104	-110	-73.00	-76.00	-79.00	-59.00	-61.00	-587	-42.00	-27.00	-32.00	-53.00	-35.00	-1,193	-51.00	-56.00	-290
Cashflow From Financing	-19.4%	-240	-201	-322	-390	-17.00	-341	-362	-123	-546	-324	-222	166	-316	-269	-231	-156	-61.00	497	-582	-92.00	-122
Dividend Payments	-	69.00	-	-	-	67.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Buy Backs	-100.0%	-	136	301	8.00	75.00	153	288	234	447	223	113	22.00	344	264	28.00	104	60.00	49.00	549	50.00	75.00

A Income Statement

2024-01-31

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Net revenue:
Net revenue	$ 1,658	$ 1,756
Costs and expenses:
Cost of revenue	750	788
Research and development	128	123
Selling, general and administrative	396	419
Total costs and expenses	1,274	1,330
Income from operations	384	426
Interest income	18	9
Interest expense	(22)	(25)
Other income (expense), net	23	0
Income before taxes	403	410
Provision for income taxes	55	58
Net income	$ 348	$ 352
Net income per share
Basic	$ 1.19	$ 1.19
Diluted	$ 1.18	$ 1.19
Weighted average shares used in computing net income per share:
Basic	293	296
Diluted	294	297
Product
Net revenue:
Net revenue	$ 1,209	$ 1,323
Costs and expenses:
Cost of revenue	514	556
Service and Other
Net revenue:
Net revenue	449	433
Costs and expenses:
Cost of revenue	$ 236	$ 232

A Balance Sheet

2024-01-31

CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($) $ in Millions	Jan. 31, 2024	Oct. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,748	$ 1,590
Accounts receivable, net	1,295	1,291
Inventory	1,033	1,031
Other current assets	262	274
Total current assets	4,338	4,186
Property, plant and equipment, net	1,314	1,270
Goodwill	3,967	3,960
Other intangible assets, net	443	475
Long-term investments	170	164
Other assets	716	708
Total assets	10,948	10,763
Current liabilities:
Accounts payable	488	418
Employee compensation and benefits	272	371
Deferred revenue	522	505
Other accrued liabilities	335	309
Total current liabilities	1,617	1,603
Long-term debt	2,555	2,735
Retirement and post-retirement benefits	102	103
Other long-term liabilities	486	477
Total liabilities	4,760	4,918
Commitments and Contingencies (Note 9 and 12)
Stockholders' equity:
Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding at January 31, 2024 and October 31, 2023	0	0
Common stock; $0.01 par value; 2,000,000,000 shares authorized; 293,041,817 shares at January 31, 2024 and 292,123,241 shares at October 31, 2023, issued and outstanding	3	3
Additional paid-in-capital	5,440	5,387
Retained earnings	1,061	782
Accumulated other comprehensive loss	(316)	(327)
Total stockholder's equity	6,188	5,845
Total liabilities and equity	$ 10,948	$ 10,763

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

WEBSITE	agilent.com
INDUSTRY	Diagnostics & Research

Agilent Technologies, Inc. Frequently Asked Questions

What is the ticker symbol for Agilent Technologies, Inc.? What does A stand for in stocks?

A is the stock ticker symbol of Agilent Technologies, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Agilent Technologies, Inc. (A)?

As of Tue Apr 23 2024, market cap of Agilent Technologies, Inc. is 40.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of A stock?

You can check A's fair value in chart for subscribers.

What is the fair value of A stock?

You can check A's fair value in chart for subscribers. The fair value of Agilent Technologies, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Agilent Technologies, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for A so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Agilent Technologies, Inc. a good stock to buy?

The fair value guage provides a quick view whether A is over valued or under valued. Whether Agilent Technologies, Inc. is cheap or expensive depends on the assumptions which impact Agilent Technologies, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for A.

What is Agilent Technologies, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, A's PE ratio (Price to Earnings) is 33 and Price to Sales (PS) ratio is 6.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. A PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Agilent Technologies, Inc.'s stock?

In the past 10 years, Agilent Technologies, Inc. has provided 0.143 (multiply by 100 for percentage) rate of return.